Topic: respiratory infections

OTC Nasal Spray Cuts COVID Infections by 67% in Trial

An over-the-counter nasal spray containing azelastine significantly reduced COVID-19 infections by 67% in a clinical trial, offering an additional layer of protection. Participants using the spray took longer to test positive and cleared the virus faster, suggesting it delays viral establishment ...